Characteristics of new adult users of mepolizumab with asthma in the USA
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characteristics of new adult users of mepolizumab with asthma in the USA
Authors
Keywords
-
Journal
BMJ Open Respiratory Research
Volume 8, Issue 1, Pages e001003
Publisher
BMJ
Online
2021-11-04
DOI
10.1136/bmjresp-2021-001003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mepolizumab add-on therapy in a real world cohort of patients with severe eosinophilic asthma: response rate, effectiveness, and safety
- (2020) Jermo Johannes van Toor et al. JOURNAL OF ASTHMA
- Adherence to omalizumab: A multicenter "real-world" study
- (2020) Raffaele Campisi et al. World Allergy Organization Journal
- Severe asthma and eligibility for biologics in a Brazilian cohort
- (2020) Luane Marques Mello et al. JOURNAL OF ASTHMA
- Real-world mepolizumab in the prospective severe asthma REALITI-A study – initial analysis
- (2020) Tim Harrison et al. EUROPEAN RESPIRATORY JOURNAL
- Omalizumab treatment patterns among patients with asthma in the US Medicare population
- (2019) Pengxiang Li et al. Journal of Allergy and Clinical Immunology-In Practice
- Trends and Disparities in Asthma Biologic Use in the United States
- (2019) Jonathan W. Inselman et al. Journal of Allergy and Clinical Immunology-In Practice
- Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations
- (2018) R. Brett McQueen et al. PHARMACOECONOMICS
- Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab
- (2018) Xuehua Ke et al. CLINICAL THERAPEUTICS
- The FDA Sentinel Initiative — An Evolving National Resource
- (2018) Richard Platt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
- (2017) Geoffrey L Chupp et al. Lancet Respiratory Medicine
- Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection
- (2017) Molly M. Jeffery et al. Journal of Allergy and Clinical Immunology-In Practice
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Theo Vos et al. LANCET
- Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma
- (2015) Susan L. Janson et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Omalizumab therapy for asthma patients with poor adherence to inhaled corticosteroid therapy
- (2015) Leslie Hendeles et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Blood Eosinophil Count Is a Risk Factor for Future Asthma Exacerbations in Adult Persistent Asthma
- (2014) Robert S. Zeiger et al. Journal of Allergy and Clinical Immunology-In Practice
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- Design considerations, architecture, and use of the Mini-Sentinel distributed data system
- (2012) Lesley H. Curtis et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A combined comorbidity score predicted mortality in elderly patients better than existing scores
- (2011) Joshua J. Gagne et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population
- (2009) Michael S. Broder et al. ALLERGY AND ASTHMA PROCEEDINGS
- Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
- (2008) Gary P Anderson LANCET
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started